Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-end Generic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prescription Drugs
1.2.3 Non-prescription Drugs
1.3 Market by Application
1.3.1 Global High-end Generic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-end Generic Drug Market Perspective (2018-2029)
2.2 Global High-end Generic Drug Growth Trends by Region
2.2.1 High-end Generic Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 High-end Generic Drug Historic Market Size by Region (2018-2024)
2.2.3 High-end Generic Drug Forecasted Market Size by Region (2024-2029)
2.3 High-end Generic Drug Market Dynamics
2.3.1 High-end Generic Drug Industry Trends
2.3.2 High-end Generic Drug Market Drivers
2.3.3 High-end Generic Drug Market Challenges
2.3.4 High-end Generic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue High-end Generic Drug by Players
3.1.1 Global High-end Generic Drug Revenue by Players (2018-2024)
3.1.2 Global High-end Generic Drug Revenue Market Share by Players (2018-2024)
3.2 Global High-end Generic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of High-end Generic Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global High-end Generic Drug Market Concentration Ratio
3.4.1 Global High-end Generic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-end Generic Drug Revenue in 2022
3.5 Global Key Players of High-end Generic Drug Head office and Area Served
3.6 Global Key Players of High-end Generic Drug, Product and Application
3.7 Global Key Players of High-end Generic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 High-end Generic Drug Breakdown Data by Type
4.1 Global High-end Generic Drug Historic Market Size by Type (2018-2024)
4.2 Global High-end Generic Drug Forecasted Market Size by Type (2024-2029)
5 High-end Generic Drug Breakdown Data by Application
5.1 Global High-end Generic Drug Historic Market Size by Application (2018-2024)
5.2 Global High-end Generic Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America High-end Generic Drug Market Size (2018-2029)
6.2 North America High-end Generic Drug Market Size by Type
6.2.1 North America High-end Generic Drug Market Size by Type (2018-2024)
6.2.2 North America High-end Generic Drug Market Size by Type (2024-2029)
6.2.3 North America High-end Generic Drug Market Share by Type (2018-2029)
6.3 North America High-end Generic Drug Market Size by Application
6.3.1 North America High-end Generic Drug Market Size by Application (2018-2024)
6.3.2 North America High-end Generic Drug Market Size by Application (2024-2029)
6.3.3 North America High-end Generic Drug Market Share by Application (2018-2029)
6.4 North America High-end Generic Drug Market Size by Country
6.4.1 North America High-end Generic Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America High-end Generic Drug Market Size by Country (2018-2024)
6.4.3 North America High-end Generic Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe High-end Generic Drug Market Size (2018-2029)
7.2 Europe High-end Generic Drug Market Size by Type
7.2.1 Europe High-end Generic Drug Market Size by Type (2018-2024)
7.2.2 Europe High-end Generic Drug Market Size by Type (2024-2029)
7.2.3 Europe High-end Generic Drug Market Share by Type (2018-2029)
7.3 Europe High-end Generic Drug Market Size by Application
7.3.1 Europe High-end Generic Drug Market Size by Application (2018-2024)
7.3.2 Europe High-end Generic Drug Market Size by Application (2024-2029)
7.3.3 Europe High-end Generic Drug Market Share by Application (2018-2029)
7.4 Europe High-end Generic Drug Market Size by Country
7.4.1 Europe High-end Generic Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe High-end Generic Drug Market Size by Country (2018-2024)
7.4.3 Europe High-end Generic Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China High-end Generic Drug Market Size (2018-2029)
8.2 China High-end Generic Drug Market Size by Type
8.2.1 China High-end Generic Drug Market Size by Type (2018-2024)
8.2.2 China High-end Generic Drug Market Size by Type (2024-2029)
8.2.3 China High-end Generic Drug Market Share by Type (2018-2029)
8.3 China High-end Generic Drug Market Size by Application
8.3.1 China High-end Generic Drug Market Size by Application (2018-2024)
8.3.2 China High-end Generic Drug Market Size by Application (2024-2029)
8.3.3 China High-end Generic Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia High-end Generic Drug Market Size (2018-2029)
9.2 Asia High-end Generic Drug Market Size by Type
9.2.1 Asia High-end Generic Drug Market Size by Type (2018-2024)
9.2.2 Asia High-end Generic Drug Market Size by Type (2024-2029)
9.2.3 Asia High-end Generic Drug Market Share by Type (2018-2029)
9.3 Asia High-end Generic Drug Market Size by Application
9.3.1 Asia High-end Generic Drug Market Size by Application (2018-2024)
9.3.2 Asia High-end Generic Drug Market Size by Application (2024-2029)
9.3.3 Asia High-end Generic Drug Market Share by Application (2018-2029)
9.4 Asia High-end Generic Drug Market Size by Region
9.4.1 Asia High-end Generic Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia High-end Generic Drug Market Size by Region (2018-2024)
9.4.3 Asia High-end Generic Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America High-end Generic Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America High-end Generic Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America High-end Generic Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Viatris
11.1.1 Viatris Company Details
11.1.2 Viatris Business Overview
11.1.3 Viatris High-end Generic Drug Introduction
11.1.4 Viatris Revenue in High-end Generic Drug Business (2018-2024)
11.1.5 Viatris Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva High-end Generic Drug Introduction
11.2.4 Teva Revenue in High-end Generic Drug Business (2018-2024)
11.2.5 Teva Recent Developments
11.3 Organon
11.3.1 Organon Company Details
11.3.2 Organon Business Overview
11.3.3 Organon High-end Generic Drug Introduction
11.3.4 Organon Revenue in High-end Generic Drug Business (2018-2024)
11.3.5 Organon Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Details
11.4.2 Sun Pharma Business Overview
11.4.3 Sun Pharma High-end Generic Drug Introduction
11.4.4 Sun Pharma Revenue in High-end Generic Drug Business (2018-2024)
11.4.5 Sun Pharma Recent Developments
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health High-end Generic Drug Introduction
11.5.4 Bausch Health Revenue in High-end Generic Drug Business (2018-2024)
11.5.5 Bausch Health Recent Developments
11.6 Mylan NV
11.6.1 Mylan NV Company Details
11.6.2 Mylan NV Business Overview
11.6.3 Mylan NV High-end Generic Drug Introduction
11.6.4 Mylan NV Revenue in High-end Generic Drug Business (2018-2024)
11.6.5 Mylan NV Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG High-end Generic Drug Introduction
11.7.4 Novartis AG Revenue in High-end Generic Drug Business (2018-2024)
11.7.5 Novartis AG Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc High-end Generic Drug Introduction
11.8.4 Pfizer Inc Revenue in High-end Generic Drug Business (2018-2024)
11.8.5 Pfizer Inc Recent Developments
11.9 Fresenius SE & Co
11.9.1 Fresenius SE & Co Company Details
11.9.2 Fresenius SE & Co Business Overview
11.9.3 Fresenius SE & Co High-end Generic Drug Introduction
11.9.4 Fresenius SE & Co Revenue in High-end Generic Drug Business (2018-2024)
11.9.5 Fresenius SE & Co Recent Developments
11.10 Lupin Limited
11.10.1 Lupin Limited Company Details
11.10.2 Lupin Limited Business Overview
11.10.3 Lupin Limited High-end Generic Drug Introduction
11.10.4 Lupin Limited Revenue in High-end Generic Drug Business (2018-2024)
11.10.5 Lupin Limited Recent Developments
11.11 Endo Pharmaceuticals Inc
11.11.1 Endo Pharmaceuticals Inc Company Details
11.11.2 Endo Pharmaceuticals Inc Business Overview
11.11.3 Endo Pharmaceuticals Inc High-end Generic Drug Introduction
11.11.4 Endo Pharmaceuticals Inc Revenue in High-end Generic Drug Business (2018-2024)
11.11.5 Endo Pharmaceuticals Inc Recent Developments
11.12 Aurobindo Pharma Limited
11.12.1 Aurobindo Pharma Limited Company Details
11.12.2 Aurobindo Pharma Limited Business Overview
11.12.3 Aurobindo Pharma Limited High-end Generic Drug Introduction
11.12.4 Aurobindo Pharma Limited Revenue in High-end Generic Drug Business (2018-2024)
11.12.5 Aurobindo Pharma Limited Recent Developments
11.13 Warner (India) Pharma Private Limited
11.13.1 Warner (India) Pharma Private Limited Company Details
11.13.2 Warner (India) Pharma Private Limited Business Overview
11.13.3 Warner (India) Pharma Private Limited High-end Generic Drug Introduction
11.13.4 Warner (India) Pharma Private Limited Revenue in High-end Generic Drug Business (2018-2024)
11.13.5 Warner (India) Pharma Private Limited Recent Developments
11.14 Shijiazhuang Pharma Group
11.14.1 Shijiazhuang Pharma Group Company Details
11.14.2 Shijiazhuang Pharma Group Business Overview
11.14.3 Shijiazhuang Pharma Group High-end Generic Drug Introduction
11.14.4 Shijiazhuang Pharma Group Revenue in High-end Generic Drug Business (2018-2024)
11.14.5 Shijiazhuang Pharma Group Recent Developments
11.15 Fosun Pharma
11.15.1 Fosun Pharma Company Details
11.15.2 Fosun Pharma Business Overview
11.15.3 Fosun Pharma High-end Generic Drug Introduction
11.15.4 Fosun Pharma Revenue in High-end Generic Drug Business (2018-2024)
11.15.5 Fosun Pharma Recent Developments
11.16 Yangtze River Pharmaceutical Group
11.16.1 Yangtze River Pharmaceutical Group Company Details
11.16.2 Yangtze River Pharmaceutical Group Business Overview
11.16.3 Yangtze River Pharmaceutical Group High-end Generic Drug Introduction
11.16.4 Yangtze River Pharmaceutical Group Revenue in High-end Generic Drug Business (2018-2024)
11.16.5 Yangtze River Pharmaceutical Group Recent Developments
11.17 Sichuan KELUN PHARMACEUTICAL Co., Ltd.
11.17.1 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Company Details
11.17.2 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Business Overview
11.17.3 Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Introduction
11.17.4 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Revenue in High-end Generic Drug Business (2018-2024)
11.17.5 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments
11.18 Nantong Beite Pharmaceutical Machinery Co.,Ltd
11.18.1 Nantong Beite Pharmaceutical Machinery Co.,Ltd Company Details
11.18.2 Nantong Beite Pharmaceutical Machinery Co.,Ltd Business Overview
11.18.3 Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Introduction
11.18.4 Nantong Beite Pharmaceutical Machinery Co.,Ltd Revenue in High-end Generic Drug Business (2018-2024)
11.18.5 Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments
11.19 CR Pharmaceutical Group
11.19.1 CR Pharmaceutical Group Company Details
11.19.2 CR Pharmaceutical Group Business Overview
11.19.3 CR Pharmaceutical Group High-end Generic Drug Introduction
11.19.4 CR Pharmaceutical Group Revenue in High-end Generic Drug Business (2018-2024)
11.19.5 CR Pharmaceutical Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global High-end Generic Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of Non-prescription Drugs
Table 4. Global High-end Generic Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global High-end Generic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global High-end Generic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global High-end Generic Drug Market Share by Region (2018-2024)
Table 8. Global High-end Generic Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global High-end Generic Drug Market Share by Region (2024-2029)
Table 10. High-end Generic Drug Market Trends
Table 11. High-end Generic Drug Market Drivers
Table 12. High-end Generic Drug Market Challenges
Table 13. High-end Generic Drug Market Restraints
Table 14. Global High-end Generic Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global High-end Generic Drug Revenue Share by Players (2018-2024)
Table 16. Global Top High-end Generic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-end Generic Drug as of 2022)
Table 17. Global High-end Generic Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by High-end Generic Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of High-end Generic Drug, Headquarters and Area Served
Table 20. Global Key Players of High-end Generic Drug, Product and Application
Table 21. Global Key Players of High-end Generic Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global High-end Generic Drug Revenue Market Share by Type (2018-2024)
Table 25. Global High-end Generic Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global High-end Generic Drug Revenue Market Share by Type (2024-2029)
Table 27. Global High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global High-end Generic Drug Revenue Share by Application (2018-2024)
Table 29. Global High-end Generic Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global High-end Generic Drug Revenue Share by Application (2024-2029)
Table 31. North America High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America High-end Generic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America High-end Generic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America High-end Generic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America High-end Generic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America High-end Generic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe High-end Generic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe High-end Generic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe High-end Generic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe High-end Generic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe High-end Generic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China High-end Generic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China High-end Generic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia High-end Generic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia High-end Generic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia High-end Generic Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia High-end Generic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia High-end Generic Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America High-end Generic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America High-end Generic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Viatris Company Details
Table 64. Viatris Business Overview
Table 65. Viatris High-end Generic Drug Product
Table 66. Viatris Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 67. Viatris Recent Developments
Table 68. Teva Company Details
Table 69. Teva Business Overview
Table 70. Teva High-end Generic Drug Product
Table 71. Teva Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 72. Teva Recent Developments
Table 73. Organon Company Details
Table 74. Organon Business Overview
Table 75. Organon High-end Generic Drug Product
Table 76. Organon Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 77. Organon Recent Developments
Table 78. Sun Pharma Company Details
Table 79. Sun Pharma Business Overview
Table 80. Sun Pharma High-end Generic Drug Product
Table 81. Sun Pharma Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 82. Sun Pharma Recent Developments
Table 83. Bausch Health Company Details
Table 84. Bausch Health Business Overview
Table 85. Bausch Health High-end Generic Drug Product
Table 86. Bausch Health Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 87. Bausch Health Recent Developments
Table 88. Mylan NV Company Details
Table 89. Mylan NV Business Overview
Table 90. Mylan NV High-end Generic Drug Product
Table 91. Mylan NV Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 92. Mylan NV Recent Developments
Table 93. Novartis AG Company Details
Table 94. Novartis AG Business Overview
Table 95. Novartis AG High-end Generic Drug Product
Table 96. Novartis AG Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 97. Novartis AG Recent Developments
Table 98. Pfizer Inc Company Details
Table 99. Pfizer Inc Business Overview
Table 100. Pfizer Inc High-end Generic Drug Product
Table 101. Pfizer Inc Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 102. Pfizer Inc Recent Developments
Table 103. Fresenius SE & Co Company Details
Table 104. Fresenius SE & Co Business Overview
Table 105. Fresenius SE & Co High-end Generic Drug Product
Table 106. Fresenius SE & Co Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 107. Fresenius SE & Co Recent Developments
Table 108. Lupin Limited Company Details
Table 109. Lupin Limited Business Overview
Table 110. Lupin Limited High-end Generic Drug Product
Table 111. Lupin Limited Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 112. Lupin Limited Recent Developments
Table 113. Endo Pharmaceuticals Inc Company Details
Table 114. Endo Pharmaceuticals Inc Business Overview
Table 115. Endo Pharmaceuticals Inc High-end Generic Drug Product
Table 116. Endo Pharmaceuticals Inc Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 117. Endo Pharmaceuticals Inc Recent Developments
Table 118. Aurobindo Pharma Limited Company Details
Table 119. Aurobindo Pharma Limited Business Overview
Table 120. Aurobindo Pharma Limited High-end Generic Drug Product
Table 121. Aurobindo Pharma Limited Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 122. Aurobindo Pharma Limited Recent Developments
Table 123. Warner (India) Pharma Private Limited Company Details
Table 124. Warner (India) Pharma Private Limited Business Overview
Table 125. Warner (India) Pharma Private Limited High-end Generic Drug Product
Table 126. Warner (India) Pharma Private Limited Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 127. Warner (India) Pharma Private Limited Recent Developments
Table 128. Shijiazhuang Pharma Group Company Details
Table 129. Shijiazhuang Pharma Group Business Overview
Table 130. Shijiazhuang Pharma Group High-end Generic Drug Product
Table 131. Shijiazhuang Pharma Group Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 132. Shijiazhuang Pharma Group Recent Developments
Table 133. Fosun Pharma Company Details
Table 134. Fosun Pharma Business Overview
Table 135. Fosun Pharma High-end Generic Drug Product
Table 136. Fosun Pharma Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 137. Fosun Pharma Recent Developments
Table 138. Yangtze River Pharmaceutical Group Company Details
Table 139. Yangtze River Pharmaceutical Group Business Overview
Table 140. Yangtze River Pharmaceutical Group High-end Generic Drug Product
Table 141. Yangtze River Pharmaceutical Group Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 142. Yangtze River Pharmaceutical Group Recent Developments
Table 143. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Company Details
Table 144. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Business Overview
Table 145. Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Product
Table 146. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 147. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments
Table 148. Nantong Beite Pharmaceutical Machinery Co.,Ltd Company Details
Table 149. Nantong Beite Pharmaceutical Machinery Co.,Ltd Business Overview
Table 150. Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Product
Table 151. Nantong Beite Pharmaceutical Machinery Co.,Ltd Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 152. Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments
Table 153. CR Pharmaceutical Group Company Details
Table 154. CR Pharmaceutical Group Business Overview
Table 155. CR Pharmaceutical Group High-end Generic Drug Product
Table 156. CR Pharmaceutical Group Revenue in High-end Generic Drug Business (2018-2024) & (US$ Million)
Table 157. CR Pharmaceutical Group Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global High-end Generic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global High-end Generic Drug Market Share by Type: 2022 VS 2029
Figure 3. Prescription Drugs Features
Figure 4. Non-prescription Drugs Features
Figure 5. Global High-end Generic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global High-end Generic Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. High-end Generic Drug Report Years Considered
Figure 11. Global High-end Generic Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global High-end Generic Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global High-end Generic Drug Market Share by Region: 2022 VS 2029
Figure 14. Global High-end Generic Drug Market Share by Players in 2022
Figure 15. Global Top High-end Generic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-end Generic Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by High-end Generic Drug Revenue in 2022
Figure 17. North America High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America High-end Generic Drug Market Share by Type (2018-2029)
Figure 19. North America High-end Generic Drug Market Share by Application (2018-2029)
Figure 20. North America High-end Generic Drug Market Share by Country (2018-2029)
Figure 21. United States High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe High-end Generic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe High-end Generic Drug Market Share by Type (2018-2029)
Figure 25. Europe High-end Generic Drug Market Share by Application (2018-2029)
Figure 26. Europe High-end Generic Drug Market Share by Country (2018-2029)
Figure 27. Germany High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China High-end Generic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China High-end Generic Drug Market Share by Type (2018-2029)
Figure 35. China High-end Generic Drug Market Share by Application (2018-2029)
Figure 36. Asia High-end Generic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia High-end Generic Drug Market Share by Type (2018-2029)
Figure 38. Asia High-end Generic Drug Market Share by Application (2018-2029)
Figure 39. Asia High-end Generic Drug Market Share by Region (2018-2029)
Figure 40. Japan High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America High-end Generic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America High-end Generic Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America High-end Generic Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America High-end Generic Drug Market Share by Country (2018-2029)
Figure 50. Brazil High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries High-end Generic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Viatris Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 57. Teva Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 58. Organon Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 59. Sun Pharma Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 60. Bausch Health Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 61. Mylan NV Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 62. Novartis AG Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 63. Pfizer Inc Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 64. Fresenius SE & Co Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 65. Lupin Limited Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 66. Endo Pharmaceuticals Inc Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 67. Aurobindo Pharma Limited Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 68. Warner (India) Pharma Private Limited Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 69. Shijiazhuang Pharma Group Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 70. Fosun Pharma Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 71. Yangtze River Pharmaceutical Group Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 72. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 73. Nantong Beite Pharmaceutical Machinery Co.,Ltd Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 74. CR Pharmaceutical Group Revenue Growth Rate in High-end Generic Drug Business (2018-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed